ABCL – abcellera biologics inc. - common shares (US:NASDAQ)
Stock Stats
News
AbCellera Biologics (ABCL) Pivots to Clinical Stage as 2025 Revenue Hits $75M [Yahoo! Finance]
AbCellera Biologics Inc (ABCL) Q4 2025 Earnings Call Highlights: Navigating Growth Amidst Challenges [Yahoo! Finance]
AbCellera Biologics Q4 Earnings Call Highlights [Yahoo! Finance]
AbCellera Reports Full Year 2025 Business Results
AbCellera Biologics (NASDAQ:ABCL) was upgraded by analysts at Wall Stree
Form 4 AbCellera Biologics Inc. For: Feb 27 Filed by: Thermopylae Holdings Ltd.
Form 4 AbCellera Biologics Inc. For: Feb 26 Filed by: Thermopylae Holdings Ltd.
Form 4 AbCellera Biologics Inc. For: Feb 27 Filed by: Booth Andrew
Form S-8 AbCellera Biologics Inc.
Form 10-K AbCellera Biologics Inc. For: Dec 31
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.